| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/23/1997 | EP0784466A1 Use and composition of an anti-sexually transmitted diseases formulation |
| 07/23/1997 | EP0753341B1 Use of hydrofluorocarbon thiolesters in emulsions, cosmetic or dermatalogical applications |
| 07/23/1997 | EP0649464B1 Transfection of vertebrate cells e.g. by homologous recombination |
| 07/23/1997 | EP0637957B1 Use of an emulsion containing omega-3 fatty acids to produce a medicament to be parenterally administered for treating inflammatory diseases |
| 07/23/1997 | EP0630229B1 Pressurized gas packagings using polyoxyethylene glyceryl-obates |
| 07/23/1997 | EP0477386B1 Pharmaceutical aerosol formulation of solid polypeptide microparticles and method for the preparation thereof |
| 07/23/1997 | CN1155247A Aqueous risperidone formulations |
| 07/23/1997 | CN1154836A Film for whitening teeth |
| 07/22/1997 | US5650489 Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof |
| 07/22/1997 | US5650486 Monomeric insulin analog formulations |
| 07/22/1997 | US5650447 Nitric oxide-releasing polymers to treat restenosis and related disorders |
| 07/22/1997 | US5650440 Method of using citramalic acid for treating wrinkles |
| 07/22/1997 | US5650437 Method of using benzilic acid for treating wrinkles |
| 07/22/1997 | US5650436 Method of using galactonic acid or galactonolactone for treating wrinkles |
| 07/22/1997 | US5650425 Anticarcinogenic, antagonist, antitumor agents and antiinflammatory agents |
| 07/22/1997 | US5650398 Drug delivery enhancement via modified saponins |
| 07/22/1997 | US5650393 Amphiphilic compounds derived from amino acids or peptides, their methods of synthesis and their application as drug delivery systems |
| 07/22/1997 | US5650390 Glycine |
| 07/22/1997 | US5650388 Fractionated polyalkylene oxide-conjugated hemoglobin solutions |
| 07/22/1997 | US5650386 Compositions for oral delivery of active agents |
| 07/22/1997 | US5650324 Inhibitor and anti-inhibitor monoclonal antibodies specific for horseradish peroxidase |
| 07/22/1997 | US5650292 Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them |
| 07/22/1997 | US5650234 For use as membrane coatings |
| 07/22/1997 | US5650172 Pharmaceutical preparation comprising fat emulsion of fat microparticles |
| 07/22/1997 | US5650171 Retinoic acid-containing polyether-polyurethane compositions |
| 07/22/1997 | US5650169 Multilayer tablet, barrier layer, polymeric excipients, partially coated with water impermeable film |
| 07/22/1997 | US5650168 Tablet with improved bioavailability containing dichloromethylenediphosphonic acid as the active substance |
| 07/22/1997 | US5650165 Percutaneous absorption preparation |
| 07/22/1997 | US5650157 Pharmaceutical compositions and methods |
| 07/22/1997 | US5650156 Encapsulation of drugs, microparticles, microemulsions, shell crosslinked by disulfide bonds |
| 07/22/1997 | US5650150 Recombinant antibody cytokine fusion proteins |
| 07/22/1997 | US5650101 Complexing a lock micelle molecule including atleast one engineered acceptor with a solution containing key micelle molecule including core and plurality of branches; used for drug delivery system |
| 07/22/1997 | US5649537 Paramagnetic metal icon chelates and use thereof as contrast agents in magnetic resonance imaging |
| 07/22/1997 | CA2107229C Taste-masked medicaments and their preparation |
| 07/22/1997 | CA2001552C Cyclophosphamide - sodium bicarbonate lyophilizates |
| 07/17/1997 | WO1997025428A1 Apo-2 ligand |
| 07/17/1997 | WO1997025404A1 Disinfecting compositions and processes for disinfecting surfaces |
| 07/17/1997 | WO1997025366A1 Polymers with controlled physical state and bioerodibility |
| 07/17/1997 | WO1997025072A1 Compositions and methods for therapeutic use |
| 07/17/1997 | WO1997025071A2 Immunoconjugate for the treatment of aids |
| 07/17/1997 | WO1997025070A2 Lipophilic peptides for macromolecule delivery |
| 07/17/1997 | WO1997025069A1 Antibodies with reduced net positive charge |
| 07/17/1997 | WO1997025068A2 Mesothelin antigen and methods and kits for targeting it |
| 07/17/1997 | WO1997025067A2 Polymers |
| 07/17/1997 | WO1997025052A2 Compositions comprising pvp having an average molecular weight in the range of 3,000 to 14,000 daltons |
| 07/17/1997 | WO1997025029A1 Preparation of tablets comprising a combination of active pellets, deformable pellets and disintegratable pellets |
| 07/17/1997 | WO1997025027A1 Granulates for cosmetic and pharmaceutical preparations |
| 07/17/1997 | WO1997025024A1 Jellied medicinal composition for oral administration |
| 07/17/1997 | WO1997025022A1 Skin care composition |
| 07/17/1997 | DE19601263A1 Anthelmintische Paste Anthelmintic paste |
| 07/17/1997 | CA2666263A1 Apo-2 ligand |
| 07/17/1997 | CA2242514A1 Immunoconjugate for the treatment of aids |
| 07/17/1997 | CA2242411A1 Disinfecting compositions and processes for disinfecting surfaces |
| 07/17/1997 | CA2242348A1 Skin care composition |
| 07/17/1997 | CA2242246A1 Lipophilic peptides for macromolecule delivery |
| 07/17/1997 | CA2241830A1 Polymers |
| 07/17/1997 | CA2241784A1 Granular materials for cosmetic and pharmaceutical preparations |
| 07/17/1997 | CA2241781A1 Preparation of tablets comprising a combination of active pellets, deformable pellets and disintegratable pellets |
| 07/16/1997 | EP0783894A1 Antibodies modified at two separate sites |
| 07/16/1997 | EP0783889A1 Pharmaceutical granulates containing an intragranular disintegrant |
| 07/16/1997 | EP0783887A2 Topical compositions for the treatment of hyperproliferative skin disease |
| 07/16/1997 | EP0783535A1 PROCESS FOR PREPARING AQUEOUS SOLUTIONS OF POLY(N-VINYL-$g(e)-CAPROLACTAM) AND THEIR USE |
| 07/16/1997 | EP0783482A1 Cationic transport reagents |
| 07/16/1997 | EP0783324A1 Cellular immunity-inducing conjugate |
| 07/16/1997 | EP0783323A1 Transfer of molecules into the cytosol of cells |
| 07/16/1997 | EP0783313A1 Cdr-grafted type iii anti-cea humanized mouse monoclonal antibodies |
| 07/16/1997 | EP0783302A1 Medicaments |
| 07/16/1997 | EP0783300A1 Starch products as tabletting excipient, method for preparing same, and method for making tablets |
| 07/16/1997 | EP0783299A1 Compounds and compositions for delivering active agents |
| 07/16/1997 | EP0783297A1 Polyethylene glycol modified ceramide lipids and liposome uses thereof |
| 07/16/1997 | EP0783296A1 Novel compositions for the introduction of polyanionic materials into cells |
| 07/16/1997 | EP0681558B1 Stable sulfide compositions, uses, and process for preparation thereof |
| 07/16/1997 | EP0642523B1 Ganglioside analogs |
| 07/16/1997 | CN1154653A Controlled release of metal cation-stabilized interferon |
| 07/15/1997 | US5648506 Water-soluble polymeric carriers for drug delivery |
| 07/15/1997 | US5648395 Method of using tartaric acid for treating wrinkles |
| 07/15/1997 | US5648391 Method of using galacturonic acid or galacturonolactone for treating wrinkles |
| 07/15/1997 | US5648388 Method of using methyllactic acid for treating wrinkles |
| 07/15/1997 | US5648344 Methods of treating inflammation using selection binding compounds |
| 07/15/1997 | US5648241 Conjugate vaccine against group B streptococcus |
| 07/15/1997 | US5648234 Biosynthesis |
| 07/15/1997 | US5648095 Volatile oil, polyether |
| 07/15/1997 | US5648093 Fast dissolving |
| 07/15/1997 | US5648088 Blends of absorbable polyoxaesters containing amines and/or amide groups |
| 07/15/1997 | US5648082 Polyamino acid dispersants |
| 07/12/1997 | CA2194730A1 Topical compositions for the treatment of skin diseases |
| 07/10/1997 | WO1997024619A1 Novel method of diagnosing and treating gliomas |
| 07/10/1997 | WO1997024453A1 Receptor specific chimeric viral surface polypeptides for viral and particle incorporation and internalization in target cells |
| 07/10/1997 | WO1997024143A1 Cytotoxic agents |
| 07/10/1997 | WO1997024142A1 Aqueous composition containing cromoglycic acid |
| 07/10/1997 | WO1997024125A2 Injectable pharmaceutical composition comprising ursodesoxycholic acid or tauroursodesoxycholic acid, a strong base and tromethamol |
| 07/10/1997 | WO1997024111A2 Novel hyaluronic acid receptors binding agents and the use thereof |
| 07/10/1997 | WO1997011682A3 Emulsion and micellar formulations for the delivery of biologically active substances to cells |
| 07/10/1997 | WO1997007769A3 Chemical compounds |
| 07/10/1997 | DE19600324A1 Granulate für kosmetische und pharmazeutische Zubereitungen Granules for cosmetic and pharmaceutical preparations |
| 07/10/1997 | CA2241515A1 Aqueous composition comprising cromoglycic acid |
| 07/10/1997 | CA2240266A1 Injectable pharmaceutical composition comprising ursodesoxycholic acid or tauroursodesoxycholic acid, a strong base and tromethamol |
| 07/09/1997 | EP0782863A1 Antibody reagent for detecting dissecting aortic aneurysm and use thereof |
| 07/09/1997 | EP0782861A1 Drug compounding ingredients comprising n-substituted-o-toluidine derivative and percutaneously absorbable preparation |
| 07/09/1997 | EP0782855A1 Antiinflammatory agent for external use |